Insights

Strategic leadership shift Recent leadership changes, including the promotion of the CFO to CEO in 2024 and subsequent leadership reshuffle, indicate a strategic pivot toward consumer wellness and operational efficiency. This presents an opportunity to position products and services that support executive decision-making, governance, and go-to-market execution.

Portfolio monetization Arcadia divested the GoodWheat high-fiber brand assets in 2024 while retaining rights to Resistant Starch Durum, suggesting a focus on core traits and a potential appetite for partnerships or licensing deals around durable, science-backed agricultural ingredients and branded consumer products.

Strategic partnerships The 2024 business combination with Roosevelt Resources and the December 2024 collaboration signals openness to strategic alliances. This creates avenues for co-development, co-marketing, or supplier-customer collaborations around novel crop traits and sustainable agriculture solutions.

Growth through tech With a late-stage trait portfolio across multiple crops and a bio-tech emphasis, Arcadia is positioned to benefit from technology partners and service providers in screening, breeding, data analytics, and trait validation to accelerate product development and commercialization.

Financial and market signals Funding of approximately $182M and revenue in the low-to-mid millions, combined with leadership focus on efficiency, indicate cost-sensitive growth opportunities. Sales prospects include tiered collaboration models, licensing fees, and performance-based agreements aligned with environmental and health-oriented product claims.

Arcadia Biosciences Tech Stack

Arcadia Biosciences uses 8 technology products and services including jsDelivr, HubSpot, PWA, and more. Explore Arcadia Biosciences's tech stack below.

  • jsDelivr
    Content Delivery Network
  • HubSpot
    Marketing Automation
  • PWA
    Miscellaneous
  • Microsoft Office
    Office Suites
  • reCAPTCHA
    Security
  • Google Analytics
    Web Analytics
  • Nginx
    Web Servers
  • Apache
    Web Servers

Media & News

Arcadia Biosciences's Email Address Formats

Arcadia Biosciences uses at least 1 format(s):
Arcadia Biosciences Email FormatsExamplePercentage
First.Last@arcadiabio.comJohn.Doe@arcadiabio.com
89%
FLast@arcadiabio.comJDoe@arcadiabio.com
9%
FirstMiddle.Last@arcadiabio.comJohnMichael.Doe@arcadiabio.com
1%
First@arcadiabio.comJohn@arcadiabio.com
1%

Frequently Asked Questions

What is Arcadia Biosciences's phone number?

Minus sign iconPlus sign icon
You can contact Arcadia Biosciences's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Arcadia Biosciences's stock symbol?

Minus sign iconPlus sign icon
Arcadia Biosciences is a publicly traded company; the company's stock symbol is RKDA.

What is Arcadia Biosciences's official website and social media links?

Minus sign iconPlus sign icon
Arcadia Biosciences's official website is arcadiabio.com and has social profiles on LinkedIn.

How much revenue does Arcadia Biosciences generate?

Minus sign iconPlus sign icon
As of July 2026, Arcadia Biosciences's annual revenue is estimated to be $1M - $10M.

What is Arcadia Biosciences's SIC code NAICS code?

Minus sign iconPlus sign icon
Arcadia Biosciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Arcadia Biosciences have currently?

Minus sign iconPlus sign icon
As of July 2026, Arcadia Biosciences has approximately 51 employees across 2 continents, including North AmericaEurope. Key team members include Owner: D. C.Owner: R. L.Senior Manager Procurement & Sourcing: I. B.. Explore Arcadia Biosciences's employee directory with LeadIQ.

What industry does Arcadia Biosciences belong to?

Minus sign iconPlus sign icon
Arcadia Biosciences operates in the Biotechnology industry.

What technology does Arcadia Biosciences use?

Minus sign iconPlus sign icon
Arcadia Biosciences's tech stack includes jsDelivrHubSpotPWAMicrosoft OfficereCAPTCHAGoogle AnalyticsNginxApache.

What is Arcadia Biosciences's email format?

Minus sign iconPlus sign icon
Arcadia Biosciences's email format typically follows the pattern of First.Last@arcadiabio.com. Find more Arcadia Biosciences email formats with LeadIQ.

How much funding has Arcadia Biosciences raised to date?

Minus sign iconPlus sign icon
As of July 2026, Arcadia Biosciences has raised $182M in funding. The last funding round occurred on Jun 11, 2026.
Arcadia Biosciences logo

Arcadia Biosciences

BiotechnologyUnited States51-200 Employees

Arcadia Biosciences is a United States–based biotechnology research company that develops and commercializes agricultural traits and products intended to benefit growers, processors and consumers while supporting environmental sustainability and human health. Using a range of screening, breeding and biotechnology methods, the company has built a diverse portfolio of late-stage traits spanning several crops. Its offerings target various points in the agricultural value chain, addressing needs for improved productivity and product quality while aligning with health-related outcomes. In 2024, Arcadia underwent leadership changes, with Thomas Schaefer advancing to chief executive officer following a mid-year restructuring. Later that year, the company announced a business combination with Roosevelt Resources, Inc., marking a strategic development.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
RKDA
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $182M

    Arcadia Biosciences has raised a total of $182M of funding over 14 rounds. Their latest funding round was raised on Jun 11, 2026as a post_ipo_equity.

  • $1M - $10M

    Arcadia Biosciences's revenue is estimated to be in the range of $1M - $10M

Section iconFunding & Financials

  • $182M

    Arcadia Biosciences has raised a total of $182M of funding over 14 rounds. Their latest funding round was raised on Jun 11, 2026as a post_ipo_equity.

  • $1M - $10M

    Arcadia Biosciences's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.